Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery.
Abstract
[BACKGROUND] There is a paucity of evidence within the plastic surgery literature concerning risk stratification and management of patients with respect to thromboembolic disease. A retrospective chart review was conducted to examine whether the Davison-Caprini risk-assessment model could stratify patients undergoing excisional body contouring surgery, allowing prophylaxis to be managed in an evidence-based manner.
[METHODS] Three hundred sixty excisional body contouring patients at the University of Texas Southwestern Medical Center in Dallas, Texas, under the senior authors' (J.M.K. and R.J.R.) care were reviewed. Patients were stratified into groups according to the risk-assessment model and into groups based on procedure. Patient characteristics were investigated for their effects on thromboembolic risk. Complications of enoxaparin administration were analyzed. The data were analyzed using appropriate statistical procedures.
[RESULTS] The highest risk patients had a significantly increased rate of venous thromboembolism when compared with lower risk patients. Body mass index greater than 30 and hormone therapy use were associated with a significantly increased venous thromboembolism rate. Enoxaparin administration was associated with a statistically significant decrease in deep venous thrombosis in circumferential abdominoplasty patients. Enoxaparin administration was associated with higher bleeding rates.
[CONCLUSIONS] Low-molecular-weight heparin may affect the incidence of postoperative thrombotic complications in some surgical populations. In this study, patients who scored greater than four risk factors were at significant risk for venous thromboembolism. Enoxaparin significantly decreased deep venous thrombosis risk in patients undergoing circumferential abdominoplasty. This demonstrates the need for a multicenter, prospective, randomized study to examine various thromboembolic therapies and associated possible complications in these patients.
[METHODS] Three hundred sixty excisional body contouring patients at the University of Texas Southwestern Medical Center in Dallas, Texas, under the senior authors' (J.M.K. and R.J.R.) care were reviewed. Patients were stratified into groups according to the risk-assessment model and into groups based on procedure. Patient characteristics were investigated for their effects on thromboembolic risk. Complications of enoxaparin administration were analyzed. The data were analyzed using appropriate statistical procedures.
[RESULTS] The highest risk patients had a significantly increased rate of venous thromboembolism when compared with lower risk patients. Body mass index greater than 30 and hormone therapy use were associated with a significantly increased venous thromboembolism rate. Enoxaparin administration was associated with a statistically significant decrease in deep venous thrombosis in circumferential abdominoplasty patients. Enoxaparin administration was associated with higher bleeding rates.
[CONCLUSIONS] Low-molecular-weight heparin may affect the incidence of postoperative thrombotic complications in some surgical populations. In this study, patients who scored greater than four risk factors were at significant risk for venous thromboembolism. Enoxaparin significantly decreased deep venous thrombosis risk in patients undergoing circumferential abdominoplasty. This demonstrates the need for a multicenter, prospective, randomized study to examine various thromboembolic therapies and associated possible complications in these patients.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | abdominoplasty
|
복부성형술 | dict | 2 | |
| 해부 | circumferential abdominoplasty
|
scispacy | 1 | ||
| 합병증 | excisional body
|
scispacy | 1 | ||
| 합병증 | thrombotic
|
scispacy | 1 | ||
| 약물 | enoxaparin
|
C0206460
enoxaparin
|
scispacy | 1 | |
| 약물 | heparin
|
C0019134
heparin
|
scispacy | 1 | |
| 약물 | [BACKGROUND]
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] Low-molecular-weight heparin
|
scispacy | 1 | ||
| 질환 | Thromboembolic
|
C0333214
thromboembolic
|
scispacy | 1 | |
| 질환 | venous thromboembolism
|
C1861172
Venous Thromboembolism
|
scispacy | 1 | |
| 질환 | venous thrombosis
|
C0042487
Venous Thrombosis
|
scispacy | 1 | |
| 질환 | bleeding
|
C0019080
Hemorrhage
|
scispacy | 1 | |
| 질환 | thrombotic complications
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | excisional body
|
scispacy | 1 | ||
| 기타 | Patient
|
scispacy | 1 | ||
| 기타 | venous
|
scispacy | 1 |
MeSH Terms
Adult; Anticoagulants; Enoxaparin; Female; Humans; Middle Aged; Obesity, Morbid; Plastic Surgery Procedures; Retrospective Studies; Risk Assessment; Thromboembolism; Treatment Outcome; Venous Thrombosis; Weight Loss
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Case report of a rare soft tissue tuberculosis in a patient undergoing lipoabdominoplasty.
- What is the potential role of the nonopioid suzetrigine in pain management?
- Ex Vivo and In Vivo Histological Evaluation of a 3-μm Wavelength, 40-μm Spot Size Fractional Laser System for Dermatology.
- Correspondence on "Lymphatic pathway remodeling in the supraumbilical region after abdominoplasty: A prospective cohort study".
- Sculpting Success-The TULUANHA: Modified TULUA Lipo-Abdominoplasty in Post-Bariatric Body Contouring.